#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor VIII deficiency Hyperinsulinaemic hypoglycaemia Synovial sarcoma Neuroblastoma Mantle cell lymphoma stage II Pleomorphic liposarcoma Leukocyte adhesion deficiency Idiopathic intracranial hypertension Ependymoma Allogenic stem cell transplantation Leiomyosarcoma recurrent Superficial vein thrombosis Cardiac amyloidosis Rheumatoid arthritis Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Treatment Osteosarcoma metastatic – Basic Information Rhabdomyosarcoma Short-bowel syndrome Castleman’s disease Hereditary hypophosphataemic rickets – Treatment SAPHO syndrome Ewing’s sarcoma recurrent – Trials in Disease Osteosarcoma – Treatment Lymphangioma – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PF-07868489 Lasmiditan Rigosertib Sodium FLUCLOXACILLIN SODIUM Darolutamide Mavorixafor Alkaline Phosphatase, Bovine Nitrofurantoin RO7268489 Ofatumumab Oritavancin Bupivacaine Hydrochloride Cyclophosphamide Monohydrate Protamine Sulfate Heparin Idarubicin 1,3-BUTYLENE GLYCOL VTX2735 SODIUM ALXN1920 GSKVX000000030918 More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage III Lymphocytic lymphoma Lymphangioleiomyomatosis Embolism venous Pancreatic carcinoma Inner ear disorder Metastatic malignant melanoma Hypochromic anaemia Rhinitis allergic Systemic scleroderma Orthostatic hypotension Chronic hepatitis C Intermittent claudication Hepatocellular carcinoma Fibromyalgia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasms

  • Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Allogenic stem cell transplantation
    Investigated drugs:
    • Human Papillomavirus Type 11 L1 Protein
    • Human Papillomavirus Type 16 L1 Protein
    • Human Papillomavirus Type 18 L1 Protein
    Sweden

  • Study on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes

    Recruiting

    2 1 1
    Investigated drugs:
    • Repotrectinib
    Belgium Denmark France Germany Hungary Italy +3

  • Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Systemic lupus erythematosus
    • Non-Hodgkin’s lymphoma
    Investigated drugs:
    • Auto4
    • Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
    • Rituximab
    Spain

  • Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Neoplasm malignant
    Investigated drugs:
    • Art6043
    • Olaparib
    Spain

  • Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

    Recruiting

    4 1 1 1
    Investigated diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated drugs:
    • Belinostat
    • Pralatrexate
    • Vincristine Sulfate
    Germany Hungary Italy Poland Spain

  • Study on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients

    Recruiting

    1 1 1
    Investigated diseases:
    • Central nervous system neoplasm
    • Non-small cell lung cancer
    Investigated drugs:
    • Apl-101
    France Hungary Italy Spain
Previous Page
1 … 95 96 97 98 99 … 516
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!